Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Sanofi India Ltd - 500674 - Announcement Under Regulation 30(5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Mr. Rodolfo Hrosz is appointed as Managing Director w.e.f 1st June 2022 subject to shareholders' approval. As required under regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors has authorised the Managing Director and Chief Financial Officer to determine materiality of an event or information in line with the said Regulations. The Board has also authorised the Company Secretary to disclose such information to the Stock Exchanges. The contact details of the above officials are as under: 1. Mr. Rodolfo Hrosz - Managing Director 2. Mr. Vaibhav Karandikar - Whole Time Director & Chief Financial Officer 3. Ms. Radhika Shah - Company Secretary Address: Sanofi House, CTS no. 117-B, L&T Business Park, Saki Vihar Road, Powai, Mumbai - 400072 Tel No.:(22) 2803 2000 Email: IGRC.SIL@sanofi.com
01-06-2022
Bigul

Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its Registrar and Share Transfer Agent on loss of share certificate(s), details of which are enclosed.
01-06-2022
Bigul

Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Please find enclosed copies of the Notice to shareholders of the Company published today, in newspapers, Business Standard and Sakal. .
26-05-2022
Bigul

Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its Registrar and Share Transfer Agent on loss of share certificate(s), details of which are enclosed.
25-05-2022
Bigul

Sanofi India Ltd - 500674 - Completion Of Dispatchment Of Postal Ballot

 Further to our letter dated 13th May 2022, this is to inform that the Company is seeking approval of Members of the Company through an Ordinary Resolution for appointment of Mr. Rodolfo Hrosz as Additional Director and Managing Director of the Company by way of Postal Ballot as detailed in the Postal Ballot Notice dated 26th April 2022. Please find enclosed copy of the Postal Ballot Notice together with the Explanatory Statement for your record. The Company has today, 23rd May 2022, sent an e-mail through Central Depository Services (India) Limited CDSL, along with the Login ID and password to the Members for e-voting who have registered their e-mail id''s with Depository Participant(s) or with the Company. The voting period will commence from Tuesday, 24th May 2022, IST at 9.00 a.m. and will end on Wednesday, 22nd June 2022 IST at 5.00 p.m. You are requested to kindly take the above information on record
23-05-2022
Bigul

Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its Registrar and Share Transfer Agent on loss of share certificate(s), details of which are enclosed:
20-05-2022
Bigul

Sanofi India Ltd - 500674 - Minutes Of The 66Th Annual General Meeting Held On 26Th April 2022

 Further to our letter dated 27th April 2022, please find enclosed herewith a copy of the minutes of the 66th Annual General Meeting of the Company held on 26th April 2022 through Video Conferencing/ Other Audio Visual Means. The same is also being uploaded on the Company's website.
20-05-2022
Bigul

Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its Registrar and Share Transfer Agent on loss of share certificate(s), details of which are as enclosed:
16-05-2022
Bigul

Sanofi India Ltd - 500674 - Revision In Postal Ballot Timelines

 We refer to our announcement dated 27th April 2022 regarding conducting of Postal Ballot for seeking the approval of members for appointment of Mr. Rodolfo Hrosz as Managing Director of the Company w.e.f 1st June 2022 by passing an Ordinary Resolution, where we had intimated the stock exchanges about the Calendar of Events. We would like to inform you regarding change in dates in the Calendar of Events for the proposed Postal Ballot process as enclosed. Kindly take the above information on record
13-05-2022
Bigul

Sanofi India Ltd - 500674 - Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended 31St December 2021

 Pursuant to Regulation 40 (9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith Certificate of M/s. Makarand M. Joshi & Co., Company Secretaries for the year ended 31st December 2021.
10-05-2022
Next Page
Close

Let's Open Free Demat Account